Aigen Investment Management, LP Charles River Laboratories International, Inc. Transaction History
Aigen Investment Management, LP
- $579 Million
- Q1 2025
A detailed history of Aigen Investment Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 1,536 shares of CRL stock, worth $216,883. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,536Holding current value
$216,883% of portfolio
0.04%Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$862 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$718 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$605 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$338 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$275 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.18B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...